Cartesian Therapeutics Inc
NASDAQ:RNAC

Watchlist Manager
Cartesian Therapeutics Inc Logo
Cartesian Therapeutics Inc
NASDAQ:RNAC
Watchlist
Price: 20.76 USD -0.1% Market Closed
Market Cap: 496m USD
Have any thoughts about
Cartesian Therapeutics Inc?
Write Note

EV/FCFF
Enterprise Value to FCFF

-6.3
Current
-17
Median
3.8
Industry
Higher than median
Lower than industry value

Enterprise Value to Free Cash Flow To Firm (EV/FCFF) ratio is a valuation multiple that compares the value of a company, debt included, to the amount of free cash flow available for all stakeholders. This metric is very similar to the EV/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.

EV/FCFF
-6.3
=
Enterprise Value
408.7m USD
/
FCFF
-65.1m USD
All Countries
Close
 
US
Cartesian Therapeutics Inc
NASDAQ:RNAC
Average EV/FCFF: 33
Negative Multiple: -6.3
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -232 027.2
US
Abbvie Inc
NYSE:ABBV
25.8
US
Amgen Inc
NASDAQ:AMGN
35.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -88.9
US
Gilead Sciences Inc
NASDAQ:GILD
11.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -483.4
AU
CSL Ltd
ASX:CSL
66.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
25.3
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.4
NL
argenx SE
XBRU:ARGX
Negative Multiple: -99.8

EV/FCFF Forward Multiples

Forward EV/FCFF multiple is a version of the EV/FCFF ratio that uses forecasted free cash flow to firm for the EV/FCFF calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to firm forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/FCFF
N/A
2-Years Forward
EV/FCFF
N/A
3-Years Forward
EV/FCFF
N/A

See Also

Discover More